Literature DB >> 15173278

Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus.

Janusz Jankowski, Paul Moayyedi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15173278     DOI: 10.1093/jnci/djh171

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  19 in total

Review 1.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

2.  Chemoprevention of esophageal adenocarcinoma.

Authors:  Julian A Abrams
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

3.  Are We Making Progress in Preventing Barrett's-Related Esophageal Cancer?

Authors:  Julian A Abrams
Journal:  Therap Adv Gastroenterol       Date:  2009-03       Impact factor: 4.409

4.  What are the therapeutic advances in gastroenterology? opinions from world experts.

Authors:  Timothy Cragin Wang; Gordon Mallarkey
Journal:  Therap Adv Gastroenterol       Date:  2008-09       Impact factor: 4.409

5.  Drinking from the fountain of promise: biomarkers in the surveillance of Barrett's oesophagus--the glass is half full!

Authors:  S L Preston; J A Jankowski
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

6.  Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma.

Authors:  Chin Hur; Tristan J Hayeck; Jennifer M Yeh; Ethan M Richards; Ethan B Richards; Stuart J Spechler; G Scott Gazelle; Chung Yin Kong
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

7.  Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis.

Authors:  Zehra B Omer; Ashwin N Ananthakrishnan; Kevin J Nattinger; Elisabeth B Cole; Jesse J Lin; Chung Yin Kong; Chin Hur
Journal:  Clin Gastroenterol Hepatol       Date:  2012-03-15       Impact factor: 11.382

8.  Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus.

Authors:  Reem Z Sharaiha; Daniel E Freedberg; Julian A Abrams; Y Claire Wang
Journal:  Dig Dis Sci       Date:  2014-05-03       Impact factor: 3.199

Review 9.  Surveillance of Barrett's oesophagus: do we yet know whether it is worthwhile?

Authors:  Margaret Somerville; Martin Pitt
Journal:  Frontline Gastroenterol       Date:  2010-06-15

10.  Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus.

Authors:  Kylie J Smith; Suzanne M O'Brien; B Mark Smithers; David C Gotley; Penelope M Webb; Adèle C Green; David C Whiteman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-11       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.